Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Goy

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
Expert Review of Hematology|July 13, 2021
Exploiting gene mutations and biomarkers to guide treatment recommendations in mantle cell lymphomaAndre Goy
Clinical Lymphoma & Myeloma|October 13, 2007
Expanding therapeutic options in mantle cell lymphomaAndre Goy, Tatyanna Feldman
Critical Reviews in Oncology/Hematology|December 21, 2010
Mantle cell lymphoma: the promise of new treatment optionsAndre Goy, Brad Kahl
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2015
Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current PracticeIrit Avivi, Andre Goy
Clinical Lymphoma|April 10, 2004
Update on the proteasome inhibitor bortezomib in hematologic malignanciesAndre Goy, Frederic Gilles
PET Clinics|May 10, 2016
Role of Positron Emission Tomography with Fludeoxyglucose F 18 in Personalization of Therapy in Patients with LymphomaAnthony R Mato, Andre Goy
Future Oncology (London, England)|April 15, 2008
Bortezomib in mantle cell lymphomaK Stephen Suh, Andre Goy
Blood|May 13, 2022
CAR T-cell therapy in highly aggressive B-cell lymphoma: emerging biological and clinical insightsAlaa Ali, Andre Goy, Kieron Dunleavy
International Journal of Molecular Sciences|June 13, 2025
From Molecular Precision to Clinical Practice: A Comprehensive Review of Bispecific and Trispecific Antibodies in Hematologic MalignanciesBehzad Amoozgar, Ayrton Bangolo, Maryam Habibi, et al.
Clinics in Geriatric Medicine|February 14, 2012
Liquid tumors in the elderlyAnthony Mato, Tatyana Feldman, Joshua Richter, et al.
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
Expert Review of Hematology|July 13, 2021
Exploiting gene mutations and biomarkers to guide treatment recommendations in mantle cell lymphomaAndre Goy
Clinical Lymphoma & Myeloma|October 13, 2007
Expanding therapeutic options in mantle cell lymphomaAndre Goy, Tatyanna Feldman
Critical Reviews in Oncology/Hematology|December 21, 2010
Mantle cell lymphoma: the promise of new treatment optionsAndre Goy, Brad Kahl
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2015
Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current PracticeIrit Avivi, Andre Goy
Clinical Lymphoma|April 10, 2004
Update on the proteasome inhibitor bortezomib in hematologic malignanciesAndre Goy, Frederic Gilles
PET Clinics|May 10, 2016
Role of Positron Emission Tomography with Fludeoxyglucose F 18 in Personalization of Therapy in Patients with LymphomaAnthony R Mato, Andre Goy
Future Oncology (London, England)|April 15, 2008
Bortezomib in mantle cell lymphomaK Stephen Suh, Andre Goy
Blood|May 13, 2022
CAR T-cell therapy in highly aggressive B-cell lymphoma: emerging biological and clinical insightsAlaa Ali, Andre Goy, Kieron Dunleavy
International Journal of Molecular Sciences|June 13, 2025
From Molecular Precision to Clinical Practice: A Comprehensive Review of Bispecific and Trispecific Antibodies in Hematologic MalignanciesBehzad Amoozgar, Ayrton Bangolo, Maryam Habibi, et al.
Clinics in Geriatric Medicine|February 14, 2012
Liquid tumors in the elderlyAnthony Mato, Tatyana Feldman, Joshua Richter, et al.
Pageof 17